Source link : https://www.newshealth.biz/health-news/novel-drug-approved-for-all-duchenne-muscular-dystrophy-variants/
The FDA approved oral givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD) in patients ages 6 years and older, the agency announced Thursday. Givinostat is a histone deacetylase (HDAC) inhibitor that targets pathogenic processes to reduce inflammation and loss of muscle. It’s the first nonsteroidal drug approved for patients with all genetic variants of DMD, […]
Author : News Health
Publish date : 2024-03-22 17:27:08
Copyright for syndicated content belongs to the linked Source.